5mg Vial
Standard therapeutic dosage
Ideal For
Active adults with recovery, healing, and tissue repair goals, after a provider review.
Recovery & Repair Peptide
Studied for Healing and Recovery
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide studied for its role in tissue repair, inflammation, and healing.
2-4
Weeks to First Review
7
Amino Acid Fragment
2-3X
Week Administration
Tβ4
Derived Fragment
Available Dosing
Physician-guided dosing tailored to your recovery and healing goals.
Standard therapeutic dosage
Ideal For
Active adults with recovery, healing, and tissue repair goals, after a provider review.
The Science
TB-500 is a synthetic peptide derived from Thymosin Beta-4, a naturally occurring protein found in high concentrations in blood platelets, wound fluid, and other tissues. This powerful peptide plays a crucial role in cell migration, proliferation, and differentiation during tissue repair.
The peptide works by promoting the upregulation of actin, a protein that forms the cytoskeleton of cells and is essential for cell movement and structure. This mechanism is thought to help cells migrate to sites of injury, which is why it is studied in the healing process.
Originally studied for its wound healing properties, TB-500 has gained attention for its potential role in supporting recovery from injuries, reducing inflammation, and supporting overall tissue health and regeneration.
Book a Consultation

How It Works
TB-500 is studied for its effects on several biological pathways involved in healing, tissue repair, and regeneration.
Studied for promoting the movement of cells to injury sites through actin upregulation, a step in healing and tissue regeneration.
Reduces inflammatory cytokines and mediates immune response, helping to decrease swelling and promote recovery.
Stimulates new blood vessel formation, improving circulation to damaged tissues and supporting nutrient delivery.
Clinical Benefits
Studied mostly in animal research for its role in recovery from tissue damage through cell migration and regeneration.
May help lower inflammatory markers and swelling during recovery.
May enhance joint and muscle flexibility by supporting connective tissue health and reducing stiffness.
Studied in animal research for effects on oxidative stress in cardiac, neurological, and muscular tissue.
May support athletic recovery from training-related microtrauma.
May promote hair follicle health and growth through improved cellular function and blood flow to the scalp.

Your Journey
Our medical team guides you through every step—from initial consultation to ongoing optimization.
Meet with our physician to discuss your health goals and healing needs.
Comprehensive evaluation to determine if TB-500 therapy is right for you.
Customized treatment plan based on your specific recovery objectives.
Ongoing guidance and adjustments as your healing progresses.

Safety & Candidacy
TB-500 peptide therapy is well-tolerated by most individuals when administered under medical supervision. Our physicians evaluate your health history to decide whether treatment is appropriate.
30+
Years of research on thymosin beta-4, the protein TB-500 is derived from
Well
Tolerated in most reports to date, with long-term human data limited

At a glance

Your plan
The consult starts with the problem, not the peptide: what was injured, when, how it was diagnosed, what imaging has shown, and what rehab you are doing. If an injury has not been properly assessed, the BHRC clinical team will recommend that first, because a peptide cannot replace a diagnosis, and some injuries need a surgeon or physical therapist before anything else. You are welcome to bring imaging reports and notes from your physical therapist or orthopedic doctor; they make the consult far more useful.
A medical history focused on cancer history, pregnancy plans, bleeding or clotting problems and current medications, plus a baseline blood panel. TB-500 is discussed in research for its effects on cell migration and blood-vessel growth, so any history of cancer gets particular attention. Blood thinners, recent surgery and planned procedures are also discussed, so the plan can be timed sensibly around them.
If the provider agrees TB-500 is reasonable, you receive a written plan covering timing, storage, injection technique, how long the block lasts and what would make you stop. The dose is set by your provider. The plan sits alongside your rehab program, not in place of it. Most people inject at home after a short teaching session, and the clinic explains how to rotate sites and dispose of needles safely.
A follow-up a few weeks in covers injection-site reactions, fatigue, headaches and how rehab is progressing. Progress is measured with the same functional markers you started with, such as range of motion, a pain score during a specific movement or a training load.
The provider and, if you agree, your physical therapist review whether function has improved. A second block is only written if there is a clear reason, and many people finish with rehab alone. If the injury has plateaued, the review may end with a referral for imaging, a sports-medicine opinion or a different rehab approach.
Timeline
Learning the injection routine and getting the vial storage right. No meaningful change is expected yet.
Some people report feeling less stiff or recovering faster between sessions, while others notice nothing. Because soft tissue heals on its own timeline, it is hard to separate the peptide from normal recovery and good rehab.
The window in which functional markers are compared with baseline. This is where rehab adherence shows up most clearly. People who kept up their exercises usually have the clearest answer, positive or negative, at this point.
A pause and a decision. Persistent or worsening pain at this point calls for reassessment of the injury, not more peptide. If things improved, the provider may suggest continuing rehab alone for a few weeks to see whether the gains hold.
Compare
| Option | What it is | Typical role | Status |
|---|---|---|---|
| TB-500 (this page) | Thymosin beta-4 fragment, injected | Adjunct to a rehab plan | Not FDA-approved; compounded |
| BPC-157 + TB-500 blends | Two recovery peptides combined | When a provider wants both mechanisms in one vial | Not FDA-approved; compounded |
| BPC-157 | Gastric-derived peptide fragment | Recovery plans, sometimes oral | Not FDA-approved; compounded |
| Structured physical therapy | Progressive loading and mobility work | The foundation of soft-tissue recovery | Standard care |
| Rest, sleep and load management | Reducing training stress while tissue adapts | Often enough for minor overuse problems | No prescription required |
Is it right for you?
Monitoring
Monitoring for TB-500 has two tracks. The first is safety: injection-site reactions, headaches, unusual fatigue, any new lumps or skin changes, and any change in your health that touches on the cancer-history question. Report spreading redness, warmth, fever or swelling near an injection site straight away.
The second is whether the plan is working. Before starting, you and your provider agree two or three functional measures, such as a range-of-motion angle, a pain score during a defined movement, or a training weight or distance. These are rechecked at the mid-block visit and at the end. If they have not improved, the provider looks at the injury and the rehab, not just the peptide.
Because FDA reports that it has not identified human exposure data for the TB-500 fragment, BHRC is conservative: short blocks, a planned pause, and a record of the compounding pharmacy and lot for every vial. A 2024 rat study found the fragment is broken down into smaller pieces within hours, and suggested that a metabolite rather than TB-500 itself may account for some reported wound-healing activity, which is a reminder of how early this science is.
Anyone using TB-500 should also know the warning signs that have nothing to do with the peptide but matter after any injury: sudden swelling in a calf, chest pain or breathlessness, a joint that becomes hot and red, or new loss of strength. These need urgent medical attention.
Regulatory status
Regulatory status: TB-500 is not an FDA-approved drug, and the vials BHRC dispenses are compounded preparations that FDA has not evaluated for safety, effectiveness or quality. FDA previously placed thymosin beta-4 fragment (LKKTETQ), also known as TB-500, in Category 2 of its 503A bulk substances interim policy, noting possible immunogenicity and impurities and that it had not identified any human exposure data for the fragment. FDA's current list, updated April 22, 2026, shows TB-500 among substances whose nominations were withdrawn by the nominators. TB-500 is prescribed at BHRC only after a consultation with a licensed provider. This page makes no claim that TB-500 treats, cures or prevents any injury or disease. Prepared by the BHRC team from FDA and PubMed sources.
Before you book
TB-500 is a small synthetic peptide based on the part of thymosin beta-4 that binds actin, the protein cells use to move and change shape. Thymosin beta-4 itself is a 43-amino-acid protein found in most cells and released by platelets at wounds. The two are related but not interchangeable, and research on one does not automatically apply to the other. When you read claims online about TB-500, it is worth checking whether the study actually used the fragment, the full protein, or a topical product, because the answer changes how much weight the claim deserves.
Much of the encouraging work is on full-length thymosin beta-4. A phase 2 trial of a topical thymosin beta-4 gel in 73 people with venous leg ulcers found it acceptably tolerated, with a signal toward faster healing at one dose, and a small 2015 trial of thymosin beta-4 eye drops in severe dry eye reported symptom improvements. Animal studies suggest roles in wound repair and blood-vessel growth. Published controlled trials of injected TB-500 in people recovering from sports injuries are lacking.
Because the fragment has not been studied in controlled human trials, there is no reliable side-effect profile. Anecdotal reports mention injection-site irritation, fatigue and headache. The theoretical concern most often raised is that a peptide associated with cell migration and blood-vessel growth could be unsuitable for anyone with cancer, which is why that is a firm exclusion at BHRC.
The proposed mechanism is that it binds actin monomers and influences how cells migrate into an injured area, along with effects on inflammation and new blood vessels described in animal studies. These mechanisms come from laboratory and animal research and have not been confirmed for the injected fragment in people.
Your provider sets the dose and schedule after the consult. For educational background on how protocols are usually described, see our TB-500 Dosage Guide. It is not a prescription.
Many recovery protocols do, and BHRC lists BPC-157 and TB-500 blends separately. Combining peptides makes it harder to know which one is helping and which one is behind a side effect, so the provider decides based on your goals and history. A single peptide is often the cleaner starting point. If a blend is chosen, the review at the end of the block is the same: functional measures, side effects and a planned pause.
Cost depends on the length of the block, how many vials it needs, whether it is part of a blend and whether follow-up labs are needed. BHRC does not list prices on this page; the clinic quotes after the consultation. Insurance does not cover compounded peptides. Physical therapy and imaging are billed separately and may be covered by your insurance even when the peptide is not.
Thymosin beta-4 and its fragments are targeted by anti-doping laboratories, which have developed tests to detect TB-500 and its metabolites in urine. If you compete in a tested sport, assume it is prohibited and check with your governing body before considering it.
At BHRC, yes. TB-500 is only dispensed after a consultation with a licensed provider. Vials sold online as research peptides are not made for human use and offer no information about purity, sterility or actual content.
It varies, and some people notice nothing. Soft-tissue healing takes weeks to months regardless of what you add, so BHRC judges the plan on functional measures at the end of the block rather than early impressions. Keeping a short weekly note of pain, stiffness and training load makes that review much more accurate.
Selected research
The literature below is peer-reviewed background on TB-500 and the mechanisms discussed on this page, so you can read the primary sources yourself. It is not evidence of any particular outcome at BHRC, and some of it is preclinical work in animals or cells. Your provider will discuss what the evidence does and does not support for your situation.
Questions
TB-500 is mainly used in supervised plans focused on tissue repair and healing goals. It is studied for effects on inflammation, cell migration to injury sites, and blood vessel formation. Athletes often ask about it for recovery from training, and it is researched for wound healing and inflammation.
TB-500 is typically administered via subcutaneous (under the skin) or intramuscular injection, usually 2-3 times per week. The injection process is simple and can be self-administered at home after proper training from our medical team. Treatment protocols typically run 4-6 weeks, with some individuals requiring longer courses depending on their healing goals.
Some patients report changes in healing and recovery within 2-4 weeks of starting TB-500 therapy, though many notice little difference and it is hard to separate from normal recovery. The timeline varies by individual. Some individuals experience benefits sooner, while more significant tissue repair may take longer to manifest fully.
TB-500 is generally reported as well tolerated, though long-term human safety data are limited. Some users may experience mild injection site reactions, temporary fatigue, or slight headaches. These effects are typically transient and resolve quickly. Report any unexpected or serious symptoms to the clinic right away.
TB-500 is sometimes combined with BPC-157 in healing-focused plans, as they are thought to act through different mechanisms; combinations have not been well studied in people. Our physicians will design the optimal protocol based on your specific health goals and review every combination for safety.
TB-500 is not recommended for individuals with active cancer, as it promotes cell growth and migration. Pregnant or nursing women should avoid TB-500 therapy. Those with certain medical conditions should consult with our physician to determine if TB-500 is appropriate. A comprehensive medical evaluation is required before starting any peptide therapy.
While both are healing peptides, TB-500 works primarily through actin upregulation and cell migration, which is why it is studied for systemic tissue repair and inflammation. BPC-157 focuses more on localized healing, gut health, and tendon/ligament repair through different mechanisms. Some plans combine both peptides for healing support after a provider review.
Get Started
Schedule a consultation with our medical team to learn if TB-500 peptide therapy is right for your wellness journey.
"*" indicates required fields

Or call us directly: +1 213-325-3373
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. TB-500 is a research peptide and is not FDA-approved for human use. Individual results may vary. A consultation with our medical team and baseline laboratory testing are required to determine if this therapy is appropriate for you.